Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Shouldn't we care about the biology of benign tumours?


While focusing on malignant tumours seems medically reasonable, from a biological perspective, benign and malignant tumours provide complementary and perhaps equally relevant perspectives on the mechanisms of tumour invasion and metastasis. However, the biology of benign neoplasms is rarely studied.

This is a preview of subscription content

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.


  1. 1

    Fearon, E. R. & Vogelstein, B. A genetic model for colorectal tumorigenesis. Cell. 61, 759–767 (1990).

    CAS  Article  PubMed  Google Scholar 

  2. 2

    Hanahan, D. & Weinberg, R. A. Hallmarks of cancer: the next generation. Cell. 144, 646–674 (2011).

    CAS  Article  PubMed  Google Scholar 

  3. 3

    Mehine, M. et al. Characterization of uterine leiomyomas by whole-genome sequencing. N. Engl. J. Med. 369, 43–53 (2013).

    CAS  Article  PubMed  Google Scholar 

  4. 4

    Dankort, D. et al. BrafV600E cooperates with Pten loss to induce metastatic melanoma. Nature Genet. 41, 544–552 (2009).

    CAS  Article  PubMed  Google Scholar 

  5. 5

    Bernards, R. & Weinberg, R. A. A progression puzzle. Nature. 418, 823 (2002).

    CAS  Article  PubMed  Google Scholar 

  6. 6

    Nguyen, D. X. & Massagué, J. Genetic determinants of cancer metastasis. Nature Rev. Genet. 8, 341–352 (2007).

    CAS  Article  PubMed  Google Scholar 

  7. 7

    Sethi, N. & Kang, Y. Unravelling the complexity of metastasis — molecular understanding and targeted therapies. Nature Rev. Cancer. 11, 735–748 (2011).

    CAS  Article  Google Scholar 

  8. 8

    Wang, Y. et al. Dystrophin is a tumor suppressor in human cancers with myogenic programs. Nature Genet. 46, 601–606 (2014).

    CAS  Article  PubMed  Google Scholar 

  9. 9

    Vogelstein, B. et al. Cancer genome landscapes. Science. 339, 1546–1558 (2013).

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  10. 10

    Egeblad, M. et al. Tumors as organs: complex tissues that interface with the entire organism. Dev. Cell. 18, 884–901 (2010).

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  11. 11

    Doyle, L. A. & Fletcher, C. D. Metastasizing “benign” cutaneous fibrous histiocytoma: a clinicopathologic analysis of 16 cases. Am. J. Surg. Pathol. 37, 484–495 (2013).

    Article  PubMed  Google Scholar 

Download references

Author information



Corresponding author

Correspondence to Christopher D. M. Fletcher.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Supplementary information

Supplementary information S1

Selected genes mutated in benign tumours of different lineages (PDF 97 kb)

PowerPoint slides

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Marino-Enriquez, A., Fletcher, C. Shouldn't we care about the biology of benign tumours?. Nat Rev Cancer 14, 701–702 (2014).

Download citation

Further reading


Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing